1. Home
  2. KNSA vs LKFN Comparison

KNSA vs LKFN Comparison

Compare KNSA & LKFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • LKFN
  • Stock Information
  • Founded
  • KNSA 2015
  • LKFN 1872
  • Country
  • KNSA United Kingdom
  • LKFN United States
  • Employees
  • KNSA N/A
  • LKFN N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • LKFN Major Banks
  • Sector
  • KNSA Health Care
  • LKFN Finance
  • Exchange
  • KNSA Nasdaq
  • LKFN Nasdaq
  • Market Cap
  • KNSA 1.9B
  • LKFN 1.6B
  • IPO Year
  • KNSA 2018
  • LKFN 1997
  • Fundamental
  • Price
  • KNSA $35.71
  • LKFN $67.93
  • Analyst Decision
  • KNSA Strong Buy
  • LKFN Buy
  • Analyst Count
  • KNSA 6
  • LKFN 2
  • Target Price
  • KNSA $40.83
  • LKFN $68.00
  • AVG Volume (30 Days)
  • KNSA 439.9K
  • LKFN 139.0K
  • Earning Date
  • KNSA 10-28-2025
  • LKFN 10-24-2025
  • Dividend Yield
  • KNSA N/A
  • LKFN 2.98%
  • EPS Growth
  • KNSA N/A
  • LKFN N/A
  • EPS
  • KNSA 0.07
  • LKFN 3.67
  • Revenue
  • KNSA $529,332,000.00
  • LKFN $239,375,000.00
  • Revenue This Year
  • KNSA $37.21
  • LKFN $16.89
  • Revenue Next Year
  • KNSA $11.99
  • LKFN $4.98
  • P/E Ratio
  • KNSA $539.78
  • LKFN $18.31
  • Revenue Growth
  • KNSA 56.18
  • LKFN N/A
  • 52 Week Low
  • KNSA $17.82
  • LKFN $50.00
  • 52 Week High
  • KNSA $35.82
  • LKFN $78.61
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 72.49
  • LKFN 61.66
  • Support Level
  • KNSA $33.25
  • LKFN $66.02
  • Resistance Level
  • KNSA $34.16
  • LKFN $69.40
  • Average True Range (ATR)
  • KNSA 0.83
  • LKFN 1.84
  • MACD
  • KNSA 0.07
  • LKFN 0.20
  • Stochastic Oscillator
  • KNSA 95.59
  • LKFN 81.90

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

Share on Social Networks: